Therapeutics: AMPA 2 glutamate receptor (GRIA2; GLUR2); glyceraldehyde-3-phosphate dehydrogenase (GAPDH)

Autoimmune disease

INDICATION: Multiple sclerosis (MS)

In vitro and mouse studies suggest a peptide that disrupts GLUR2-GAPDH

Read the full 157 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE